SEC Filing Details

Our enduring purpose: To fundamentally improve the lives of patients with serious diseases in ways never before possible

SEC Filing Details

Document Details

Form
Filing Date
Apr 20, 2012
Document Date
Apr 20, 2012
Filing Group
Other
Company
Five Prime Therapeutics
Issuer
FIVE PRIME THERAPEUTICS, INC.